TY - JOUR
T1 - Arboviral Infections in Neurological Disorders in Hospitalized Patients in São José do Rio Preto, São Paulo, Brazil
AU - Milhim, Bruno H.G.A.
AU - da Rocha, Leonardo C.
AU - Terzian, Ana C.B.
AU - Mazaro, Carolina C.P.
AU - Augusto, Marcos T.
AU - Luchs, Adriana
AU - Zini, Nathalia
AU - Sacchetto, Livia
AU - Dos Santos, Barbara F.
AU - Garcia, Pedro H.C.
AU - Rocha, Rodrigo S.
AU - Liso, Elisabete
AU - Brienze, Vânia M.S.
AU - da Silva, Gislaine C.D.
AU - Vasilakis, Nikos
AU - Estofolete, Cássia F.
AU - Nogueira, Maurício L.
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/7
Y1 - 2022/7
N2 - Arbovirus infections are increasingly important causes of disease, whose spectrum of neurological manifestations are not fully known. This study sought to retrospectively assess the incidence of arboviruses in cerebrospinal fluid samples of patients with neurological symptoms to inform diagnosis of central and peripheral nervous system disorders. A total of 255 cerebrospinal fluid (CSF) samples collected from January 2016 to December 2017 were tested for dengue virus (DENV 1-4), Zika virus (ZIKV), and Chikungunya virus (CHIKV) in addition to other neurotropic arboviruses of interest, using genetic and serologic assays. Of the 255 CSF samples analyzed, 3.53% (09/255) were positive for arboviruses presenting mainly as meningitis, encephalitis, and cerebrovascular events, of which ZIKV was detected in 2.74% (7/255), DENV in 0.78% (2/255), in addition to an identified ILHV infection that was described previously. All the cases were detected in adults aged 18 to 74 years old. Our findings highlight the scientific and clinical importance of neurological syndromes associated with arboviruses and demonstrate the relevance of specific laboratory methods to achieve accurate diagnoses as well as highlight the true dimension of these diseases to ultimately improve public health planning and medical case management.
AB - Arbovirus infections are increasingly important causes of disease, whose spectrum of neurological manifestations are not fully known. This study sought to retrospectively assess the incidence of arboviruses in cerebrospinal fluid samples of patients with neurological symptoms to inform diagnosis of central and peripheral nervous system disorders. A total of 255 cerebrospinal fluid (CSF) samples collected from January 2016 to December 2017 were tested for dengue virus (DENV 1-4), Zika virus (ZIKV), and Chikungunya virus (CHIKV) in addition to other neurotropic arboviruses of interest, using genetic and serologic assays. Of the 255 CSF samples analyzed, 3.53% (09/255) were positive for arboviruses presenting mainly as meningitis, encephalitis, and cerebrovascular events, of which ZIKV was detected in 2.74% (7/255), DENV in 0.78% (2/255), in addition to an identified ILHV infection that was described previously. All the cases were detected in adults aged 18 to 74 years old. Our findings highlight the scientific and clinical importance of neurological syndromes associated with arboviruses and demonstrate the relevance of specific laboratory methods to achieve accurate diagnoses as well as highlight the true dimension of these diseases to ultimately improve public health planning and medical case management.
KW - arbovirus
KW - neurological disorders
KW - surveillance
UR - http://www.scopus.com/inward/record.url?scp=85133739786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133739786&partnerID=8YFLogxK
U2 - 10.3390/v14071488
DO - 10.3390/v14071488
M3 - Article
C2 - 35891468
AN - SCOPUS:85133739786
SN - 1999-4915
VL - 14
JO - Viruses
JF - Viruses
IS - 7
M1 - 1488
ER -